Tobradex

Tobradex Adverse Reactions

tobramycin + dexamethasone

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Adverse Reactions
The following adverse reactions have been reported during clinical trials with Tobradex Ophthalmic Suspension/Ointment and are classified according to the subsequent convention: very common (≥ 1/10), common (≥ 1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000). Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness. (See Table 1.)

Click on icon to see table/diagram/image

Additional adverse reactions identified from post-marketing surveillance include the following. Frequencies cannot be estimated from the available data. (See Table 2.)

Click on icon to see table/diagram/image

Additional adverse reactions reported with the individual components of Tobradex Ophthalmic Suspension and Ointment are listed in the product information for Maxidex Eye Drops and/or Eye Ointment and Tobrex Eye Drops and/or Tobrex Eye Ointment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in